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Abstract
Background: Deep brain stimulation (DBS) for essential tremor (ET) can cause unwanted side effects.
Case Report: A patient with ET underwent unilateral dual-lead thalamic DBS. He later developed parkinsonism with atypical features and was diagnosed with
progressive supranuclear palsy. During presentation for a second opinion, stimulation-induced side effects were suspected. Inactivation of DBS resolved atypical
features and superimposed idiopathic Parkinson disease (PD) was diagnosed.
Discussion: This case illustrates the importance of recognizing the possible influence of stimulation-induced side effects and discusses when to utilize dual-lead
DBS for ET and the co-occurrence of ET and PD.
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Introduction
Thalamic deep brain stimulation (DBS) is a generally well-tolerated
therapy for medically refractory essential tremor (ET). Side effects of
stimulation can include changes in speech, gait, and cognition and are
more likely to occur with higher voltages due to spread of current to
surrounding structures. It is important to consider the possibility of
stimulation induced side effects when new symptoms arise.
Case Report
An 81-year-old male with a 15-year history of ET underwent DBS
surgery at an outside institution 6 years before presentation. Initially,
a left ventralis intermedius (VIM) DBS failed to produce a reduction in
tremor, so the decision was made to place a second DBS lead into the
left VIM region during the same operative procedure. Tremor reduc-
tion was observed intraoperatively and deemed to be sufficient after
the second lead was placed. Both leads were connected to a dual-channel
implantable pulse generator. Over the subsequent 4-year period, the
voltage settings of both leads were gradually increased to address
incomplete tremor control. Two years before presentation to our center,
the patient gradually developed significant cognitive impairment, speech
difficulty, and abnormal eye movements associated with parkinsonism.
Previous records documented severe gait impairment, square wave
jerks with saccadic pursuits, as well as slow and incomplete vertical
and horizontal saccades. The patient underwent neuropsychological
testing, which demonstrated significant frontal-subcortical dysfunction
and he was diagnosed with PSP (Progressive Supranuclear Palsy),
although at no time during his neurologic or neuropsychological evalua-
tion was his stimulation turned off. Levodopa was initiated and titrated
up to 200 mg administered three times per day. The medication trial
was complicated by mild visual hallucinations that resolved with the
addition of quetiapine 50 mg administered at bedtime. He presented
to the North Florida South Georgia VA Medical Center/University
of Florida for a second opinion of the diagnosis of PSP. On his
initial examination, he was non-ambulatory with marked inattention,
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decreased responsiveness, and expressive aphasia. The presence of
supranuclear gaze palsy could not be confirmed, because of inattention
and poor cooperation; however, there were clear abnormalities of
vertical gaze on smooth pursuit. Both thalamic region DBS leads were
confirmed as activated during the evaluation: lead A 1-2-C+ 5.0 V,
150 ms, 200 Hz; lead B 4-5-C+ 5.0 V, 120 ms, 200 Hz. A lead local-
ization scan was performed using computed tomography imaging
(Figure 1).
The prior neurologic evaluation and neuropsychiatric evaluation
resulting in the diagnosis of PSP were conducted without regard to
DBS status or settings. The high-voltage settings raised the possibility
that at least some component of his neurologic abnormalities could
be stimulation related. A complete neurologic examination was sub-
sequently performed with both DBS leads turned off. A few minutes
following inactivation, the patient was observed to have an immediate
and dramatic improvement in his level of alertness, cognition, speech,
and his ability to ambulate. He had normalization of his eye move-
ments with full horizontal and vertical saccades. He was able to
speak in full sentences and walk independently. Although he remained
moderately parkinsonian, immediate resolution of many of his symp-
toms suggested that the atypical PSP-like features were stimulation
induced. His Unified Parkinson Disease Rating Scale Part III motor
score was performed on medication and off stimulation and the score
was 35. Moderate postural and action tremor consistent with the initial
diagnosis of ET was noted on testing, including spiral drawing and
pouring water. Collectively, the examination findings off stimulation
suggested that the initial preoperative diagnosis of ET was correct and
that the patient had developed parkinsonism since DBS implantation.
DaTSCAN was performed and demonstrated asymmetrically decreased
radiotracer uptake in the posterior right basal ganglia, consistent with
a neurodegenerative etiology of parkinsonism as well. The lack of
atypical features in the off-stimulation state suggested that the cause of
his parkinsonism was idiopathic PD rather than PSP, and that much
of his cognitive, language, and gait abnormalities were secondary to
gradual increases in his DBS settings resulting in excessive stimulation
of VIM and surrounding structures (e.g., the internal capsule).
The DBS settings for lead 1 (the anterior lead) were reduced and
lead 2 (the posterior lead) was completely inactivated. This decision
was based on the clinical responses from empirical bedside programming.
Although it is counterintuitive to turn off the posterior (VIM) lead and
program using solely the anterior (ventralis oralis anterior/ventralis
oralis posterior (VOA/VOP)) lead, we suspect that the posterior (VIM)
lead was causing capsular side effects because of its lateral placement.
The final settings after this initial consultation were lead 1 1-2-C+ 4.0 V,
90 ms, 160 Hz; lead 2 off. Following the re-programming session, the
patient’s speech was fluent and the ability to walk independently was
restored.
The patient continued with carbidopa–levodopa 25/100 mg, two
tablets three times per day. Throughout his follow-up visits, the patient
has continued to ambulate independently and resumed driving. He
reports that he does his grocery shopping and banking independently.
No atypical features have recurred and he has a positive response to
levodopa therapy.
Discussion
This case brings up several interesting issues.
The most salient point is to recognize that high-voltage stimulation
within the VIM can result in side effects and that these side effects can
be a source of diagnostic errors. VIM DBS is in general an effective
and well-tolerated therapy for medication refractory essential tremor
(ET).1,2 The usual preferred lead location within the VIM target places
the tip of the lead 1–2 mm anterior to the VC (ventralis caudalis) border
with the 0 (deep) contact at or below the ventral boundary of the VIM.
Figure 1. Lead Location. The anterior lead is 6.8 mm posterior, 15.9 mm lateral, and 4.7 mm ventral to the mid-commissural point using the AC–PC line as
a reference system. The posterior lead is 10.1 mm posterior, 16.5 mm lateral, and 3.3 mm ventral. Both leads were lateral based on lead measurement.
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These coordinates can vary depending on lead trajectory and many sur-
geons place the deepest contact below the AC–PC (anterior commissure–
posterior commissure) line into the zone incerta region. If the lead is
laterally placed, fibers of the posterior limb of the internal capsule can
be stimulated, resulting in side effects similar to those seen in the above
case: dysarthria, facial pulling, eye movement abnormalities, or limb
pulling. If the lead is posteriorly placed, the VC nucleus can be stimulated,
resulting in paresthesia. These are the most common side effects;
however, changes in gait and cognition have also been reported.3 Post-
operative imaging can be useful to predict potential side effects based on
the anatomical lead location. We suggest obtaining postoperative
imaging and performing lead measurement before the initial program-
ming to help guide setting adjustments.
It is well established that side effects from stimulation are more likely
to occur when utilizing higher voltages, presumably because of spread
of the electrical current outside the target and into the larger surround-
ing area. We suggest performing monopolar threshold testing for side
effects and benefits at each electrode contact at the time of the initial
programming. Even when programming is optimal, disease progres-
sion often results in a perceived loss of benefit over time and a gradual
increase in stimulation parameters (though in rare cases tolerance to
the DBS has been hypothesized).4–6 As a result, it is not uncommon
that DBS voltage will be slowly increased over the course of many
outpatient visits and the gradual onset of stimulation-induced side
effects can be overlooked, resulting in unintended overstimulation,3,7
as occurred in this patient. In any patient who has undergone DBS
implantation, it is important to consider the possibility of stimulation-
induced side effects when new complaints develop. Some side effects
(such as gait dysfunction) may not be immediately apparent during or
after a programming session. Finally, it is critically important that
neurologic and neuropsychological evaluations in patients with DBS
occur off stimulation to control for possible stimulation-induced side
effects.
In this case, side effects from overstimulation were likely com-
pounded by the immediate addition of a second DBS lead. Details
regarding this decision are not known, but in a majority of cases a well-
placed VIM lead is sufficient for tremor suppression. If tremor
suppression cannot be obtained intraoperatively, the next step should
be to consider suboptimal lead placement. This information can be
obtained from the microelectrode recording data, and the side effect
thresholds obtained during macrostimulation. If the lead is subopti-
mally placed, the lead should be adjusted, negating the need for a
second lead. In exceptional cases of refractory tremor, especially for
proximal severe tremor, dual-lead DBS for ET, either in the initial
surgery or as rescue therapy, has been proposed.8–10 Proposed loca-
tions for the second lead include the VOA nucleus of the thalamus,
which is a pallidal receiving area,8 the prelimniscal radiations, which
contain cerebello-thalamic afferents,11 and the zona incerta. This
approach might improve tremor control by increasing the total
volume of tissue activation or by differentially affecting two separate
tremor-generating circuits.10 There is evidence that this strategy can
be effective;8,12 however, there is no clear consensus on when this
strategy should be utilized. There is also no evidence comparing dual
intraoperative leads versus initial VIM placement followed by a rescue
lead in select cases when benefit from the VIM lead is deemed
unsatisfactory. A general approach to programming simultaneous
intraoperative thalamic leads at our center is to perform monopolar
thresholds to identify side effects and benefits for each electrode
contact and then to activate and optimize one lead, over a period of
months. After a period of initial optimization with the first lead,
if needed, the second lead is additionally activated and optimized.
In a small published case series of dual VIM/VOA leads, combined
voltages ranged from 5 V to 7.1 V.12 The patient above was receiv-
ing a significantly higher combined voltage of 10 V. Despite higher
voltages it remains reasonable to expect that having dual leads in close
proximity, each at high voltage, would increase the overall risk for side
effects simply because of an overlapping, and also wider, dispersal of
the electrical current.
A final interesting aspect of this case is the development of super-
imposed idiopathic PD in a patient with DBS for ET. Both ET and PD
are common movement disorders and may co-occur by chance alone.
However, epidemiological studies support the idea that there may be
an association between ET and the development of PD in select
cases.13–15 One review suggests that the magnitude of the increased
odds/risk is on the order of 3–13.13 This epidemiological link is not
well understood despite clinical, imaging, genetic, and pathological
study, and the link remains somewhat controversial among the
experts.16 In this case, parkinsonism developed long after the onset of
action tremor and after DBS surgery; however, initial misdiagnosis of
PD as ET has been considered as a factor in the relationship between
the two diseases. There is currently no evidence to suggest that patients
with ET who undergo DBS surgery are at greater risk of developing
idiopathic PD than their non-DBS cohort.
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